Pascal Heberling

Pascal Heberling is a seasoned private equity professional with over two decades of experience in the industry. He currently serves as Partner and Co-Head of Europe at 65 Equity Partners, based in London.12

Career Highlights

Private Equity Experience:: Pascal has had an impressive career trajectory in private equity, with notable positions at several prominent firms:

1. 65 Equity Partners: Currently Partner and Co-Head of Europe.12
2. BC Partners: Previously a Partner focusing on healthcare, where he led the investment in CeramTec.1
3. Abu Dhabi Investment Authority (ADIA): Spent over six years as Head of Healthcare and a member of its Executive Committee.1
4. Cinven: Worked for twelve years, including nine years as a Partner.1

Investment Leadership:: Throughout his career, Pascal has led numerous successful investments, particularly in the healthcare sector:

• At ADIA: Led investments in Galderma (Nestlé Skin Health), Pharmaceutical Product Development (PPD), and Moderna.1
• At Cinven: Played a key role in investments including Spire Healthcare, Numéricable, MediMedia, and Springer Science (now Springer Nature).1

Education and Skills

Pascal Heberling has a strong educational background:

• Graduated summa cum laude from the Institut d'Études Politiques de Paris (Sciences Po).1
• Holds an MA and an MBA from the University of Toronto (dean's list).1

He is trilingual, fluent in English, French, and German.1

Recent Developments

Pascal joined 65 Equity Partners in 2023 as part of a major boost to the firm's senior leadership team.3 His appointment, along with that of Leon Brujis, signifies the company's commitment to strengthening its presence in Europe and the United States.4

With his extensive experience in healthcare investments and his multilingual skills, Pascal Heberling brings valuable expertise to his role at 65 Equity Partners, particularly in the European market.